Discussion on: Clinical and Risk Factor Profile of Infants Treated with Bevacizumab or Nd: YAG Laser for Retinopathy of Prematurity

Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.

Article Title
Clinical and Risk Factor Profile of Infants Treated with Bevacizumab or Nd: YAG Laser for Retinopathy of Prematurity
Authored by

Salwa Khan
Department of Neuro-Opthalmology, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh.

Sohel Mahmud
Department of Opthalmology, MH Samorita Hospital & Medical College, Dhaka, Bangladesh.

Dipak Kumer Nag
Department of Vitreo-Retina, National Institute of Ophthalmology and Hospital, Dhaka, Bangladesh.

Md. Shakhawat Hossain
Department of Cornea and Anterior Segment, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh.

Sabiha Farhana Islam
Department of Cornea and Anterior Segment, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh.

Tasnuva Khan
Department of Pediatrics, Upzila Health Complex, Sreenagar, Munshiganj, Bangladesh.

Safinaz Khan
Department of Biochemistry, Bangladesh Medical University, Dhaka, Bangladesh.

DOI or Article Link

https://doi.org/10.9734/or/2025/v20i4470

Leave a Comment